Literature DB >> 10433518

Protein phosphatase 2A suppresses MAP kinase signalling and ectopic protein expression.

H Chung1, D L Brautigan.   

Abstract

Signalling by MAP kinase was examined in COS-7 cells by transiently expressing a transcription reporter system plus epitope-tagged protein phosphatase 2A catalytic subunit [(HA)3-PP2Ac]. Transactivation of a luciferase gene by GAL4-Elk-1 in serum-stimulated cells was reduced 20-fold by co-expression of wild type (HA)3-PP2Ac. This reduction of MAP kinase signalling required specific type-2A phosphatase activity, because the effects were not mimicked by co-expression of either a mutated, inactive (HA)3-PP2Ac or wild-type PP1Cdelta. Expression of (HA)3-PP2Ac was severely restricted by its own activity because 3-fold more inactive (HA)3-PP2Ac was produced. In a different assay the kinase activity of FLAG-ERK2 was 4-fold lower when co-transfected with (HA)3-PP2Ac, compared to controls. Unexpectedly, mRNA of the reporter constructs were nearly eliminated by even low level expression of (HA)3-PP2Ac in either COS7 or HEK293 cells. The results show that PP2A activity is strictly regulated and can be a limiting factor in ectopic expression of various proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433518     DOI: 10.1016/s0898-6568(99)00033-9

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  18 in total

1.  Active-site mutations impairing the catalytic function of the catalytic subunit of human protein phosphatase 2A permit baculovirus-mediated overexpression in insect cells.

Authors:  T Myles; K Schmidt; D R Evans; P Cron; B A Hemmings
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

2.  p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.

Authors:  J Westermarck; S P Li; T Kallunki; J Han; V M Kähäri
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

3.  Important role for phylogenetically invariant PP2Acalpha active site and C-terminal residues revealed by mutational analysis in Saccharomyces cerevisiae.

Authors:  D R Evans; B A Hemmings
Journal:  Genetics       Date:  2000-09       Impact factor: 4.562

4.  Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease.

Authors:  Jin-Jing Pei; Cheng-Xin Gong; Wen-Lin An; Bengt Winblad; Richard F Cowburn; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

5.  Protein phosphatase 2A is a negative regulator of transforming growth factor-beta1-induced TAK1 activation in mesangial cells.

Authors:  Sung Il Kim; Joon Hyeok Kwak; Lin Wang; Mary E Choi
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

6.  Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice.

Authors:  Stefan Kins; Pascal Kurosinski; Roger M Nitsch; Jürgen Götz
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

7.  Alpha4 is an essential regulator of PP2A phosphatase activity.

Authors:  Mei Kong; Dara Ditsworth; Tullia Lindsten; Craig B Thompson
Journal:  Mol Cell       Date:  2009-10-09       Impact factor: 17.970

8.  Protein phosphatase 2A enables expression of interleukin 17 (IL-17) through chromatin remodeling.

Authors:  Sokratis A Apostolidis; Thomas Rauen; Christian M Hedrich; George C Tsokos; José C Crispín
Journal:  J Biol Chem       Date:  2013-08-05       Impact factor: 5.157

9.  Status epilepticus-induced somatostatinergic hilar interneuron degeneration is regulated by striatal enriched protein tyrosine phosphatase.

Authors:  Yun-Sik Choi; Stanley L Lin; Boyoung Lee; Pradeep Kurup; Hee-Yeon Cho; Janice R Naegele; Paul J Lombroso; Karl Obrietan
Journal:  J Neurosci       Date:  2007-03-14       Impact factor: 6.167

Review 10.  Anp32e (Cpd1) and related protein phosphatase 2 inhibitors.

Authors:  Tomás A Santa-Coloma
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.